Skip to main content

Table 5 Factors associated with non-susceptibility to ciprofloxacin, nalidixic acid or erythromycin among a cohort of Campylobacter-associated hospitalisations (n = 548)

From: Bacteraemia, antimicrobial susceptibility and treatment among Campylobacter-associated hospitalisations in the Australian Capital Territory: a review

Predictor variable

Estimated adjusted Odds Ratio (aOR)

95 % Confidence Interval

p-value

Recent overseas travel

11.80

3.18–43.83

< 0.001

Previous Campylobacter-associated hospitalisation

17.09

2.65−110.07

< 0.01

Tachycardia

0.48

0.26–0.89

0.02

  1. Hosmer and Lemeshow goodness of fit χ2  = 0.01,  p = 0.92